Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

PRP shows promise in treating urological diseases but needs more research.

The method accurately measures Finasteride and Tamsulosin in tablets without interference.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Finasteride improves prostate cancer detection in PSA test.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

New methods for measuring dutasteride are effective and reliable.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Using real-time ultrasound during gluteal fat grafting is safe and reduces complication risks.

Men over 50 often experience urinary issues due to prostate enlargement or bladder problems, treatable with therapies, medications, or surgery.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Dutasteride may help prevent prostate cancer, but more research is needed.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

BPH treatments can cause sexual side effects affecting quality of life.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

New method accurately measures finasteride in tablets and bulk.